Research and Markets (http://www.researchandmarkets.com/research/f4jkpw/global) has announced the addition of the "Global Schizophrenia Therapeutics Market 2014-2018" report to their offering.
The Global Schizophrenia Therapeutics market to grow at a CAGR of 2.82% over the period 2013-2018
One major trend in this market is the increase in the awareness of schizophrenia. The awareness among patients and physicians is expected to increase the penetration of drugs in the market.
According to the report, an increase in the aging population worldwide is one of the main drivers of the market. Aging is one of the main causes of CNS disorders, including schizophrenia. Therefore, the global burden of the disorder is increasing because of the rapidly aging population in different parts of the world.
Further, the report states that an increase in the generic competition is one of the main challenges that the market confronts. The availability of low-cost generic drugs intensifies the competition among the vendors and thus substantially reduces the cost of patented/branded drugs.
The Global Schizophrenia Therapeutics market can be segmented into two:
- First-generation Antipsychotics
- Second-generation Antipsychotics
Key Vendors
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lily
- F. Hoffmann-La Roche
- H. Lundbeck
- Johnson & Johnson
- Otsuka Pharmaceuticals
- Pfizer
- Sumitomo Dainippon Pharma
Key Topics Covered:
- Executive Summary
- List of Abbreviations
- Scope of the Report
- Market Research Methodology
- Introduction
- Market Landscape
- Pipeline Snapshot
- Rate of Incidence and Prevalence
- Types of Schizophrenia
- Phases of Schizophrenia
- Market Segmentation by Drug Class
- Geographical Segmentation
- Buying Criteria
- Market Growth Drivers
- Drivers and their Impact
- Market Challenges
- Impact of Drivers and Challenges
- Market Trends
- Trends and their Impact
- Vendor Landscape
- Key Vendor Analysis
For more information visit http://www.researchandmarkets.com/research/f4jkpw/global.
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals